Comprehensive and Cost-Effective Compliance Training
Upcoming Featured Courses
- Configuration Control vs. Document Control – Managing Design Changes Across Modern Quality Systems
- Risk-based Excel Spreadsheet Validation - 2026 Updates
- Human Error Trends as AI Enters GMP Operations: What QA Leaders Should Expect and Monitor
- Using SPC and Process Data to Support Quality, Stability, and Manufacturing Decisions
- OTC Monograph Reform and OMUFA II: What FDA’s Modernized OTC Framework Means for Manufacturers
- Nitrosamines After the Initial Assessment: When Does a Change Trigger Reassessment and How Should Impact Be Evaluated
- Measuring SOP Effectiveness Across Training, Qualification, GMP Operations, and AI-assisted environments
Featured On-Demand Courses
- EO Sterilization Validation and Revalidation Under ISO 11135: Practical Implementation and Lifecycle Considerations
- Acceptance Criteria for AI Validation: Determining What “Reliable” Actually Means in GxP Systems
- Aseptic Processing and Contamination Control Under EU GMP Annex 1: Practical Applications for Modern Sterile Operations
- Audit Trail Review by Exception: Reducing Reviewer Burden Without Weakening Detection
- AI-Assisted Post-Market Surveillance and Signal Detection: What Regulators Will Still Expect Humans to Defend
- Root Cause Analysis for GMP Investigations: Identifying Systemic Failures and Building Effective CAPA
- IQ, OQ & PQ: What Now Counts as Sufficient Validation Evidence
- ChatGPT-Assisted Technical Writing
- Digital Quality Metrics and AI/ML Analytics: Building a Continuous-Improvement Framework that Aligns with Regulatory Expectations
- AI Errors May Be Impossible to Eliminate – What That Means for Its Use in the FDA
- HPLC Analytical Method Development and Validation
- The First FDA Warning Letter on AI: What It Means for Your Quality System
- AI for CAPA and Investigations: Where It Helps and Where It Can Get You in Trouble
- Validating AI Use in Quality Systems: Practical CSV and CSA Approaches for FDA Inspection Readiness
- Environmental Monitoring Programs: Development, Implementation, and Evolving FDA Expectations for Controlled Environments
- OOS Investigations: Decision-Making in Practice and FDA Expectations for 2026
- Validating Cloud & Digital GxP Systems Using a CSV/CSA Approach
- Risk-based Excel Spreadsheet Validation
- OOS and OOT Investigations Course
- FDA Inspections After QMSR: What Replaces QSIT 2.0 - The New Inspection Reality
- ChatGPT and AI-Powered Project Management - Revolutionize your Projects Now
- The FDA Medical Device File (DHF, DMR, DHR, Market Authorizations) and EU MDR Technical Documentation
- Leveraging AI in Risk Assessment for Smarter Computer Systems Validation
© All rights reserved